MedTrace Logo

Bayston Multicenter Antimicrobial PD Catheter Safety Study

NCT02274896 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-09-15

No results posted yet for this study

Summary

The study was designed to establish the safety of the Bayston Antimicrobial PD catheter that is impregnated with a "cocktail" of three well known anti-microbials

Conditions

  • End Stage Renal Disease (ESRD)

Interventions

DEVICE

PD Catheter group

PD catheter

Sponsors & Collaborators

  • Medical Components, Inc dba MedComp

    lead INDUSTRY

Principal Investigators

  • Martin Wilkie, Dr. · Renal consultant

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Belgium
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02274896 on ClinicalTrials.gov